NLS Business

The launch of Pixelgen Technologies follows the close of an approximate 6 million USD seed round, led by Navigare Ventures. The founding will support the commercialization next year of the company’s Molecular Pixelation technology for spatial analyses of cell surface proteins in 3D. “We are pioneering a completely new approach to spatial proteomics with Molecular […]

Abera Bioscience has found the right recipe for giving its innovative and versatile vaccine platform the best possible conditions to succeed. Uppsala-based Abera Bioscience was founded ten years ago, as a spin-out from the biosimilars company Xbrane Bioscience. Maria Alriksson, CEO of Abera and former CEO of Xbrane, describes the process of separating the two […]

Immunotherapy company Valo Therapeutics could play an important part in modern cancer care, using a highly adaptable platform effective for a wide range of cancers. Valo Therapeutics (ValoTx), founded in 2016, is a spin-out from Helsinki University and the research of Professor Vincenzo Cerullo. Professor Cerullo’s research group developed the unique technology platform, named PeptiCRAd […]

This up-and-coming star on the global biotech scene aims to crack the hard code of finding better treatments for neurodegenerative diseases.

DoMore Diagnostics, one of our NLS Stars 2022, aims to change the one-size-fits-all approach in cancer therapy. Cancer is a growing global public health problem, and the cost of cancer care is expected to double the next 20 years. It is a leading cause of death worldwide and accounted for nearly 10 million deaths in […]

Umeå Biotech Incubator (UBI) is launching the ‘UBI International Coaching Program’, with the first course starting on October 24th. “If you strive to be one of the world’s best incubators you must have the whole world as your marketplace”, says Jennie Ekbeck, CEO of UBI. “Our role is to help companies develop solutions that meet […]